CBIO
Crescent Biopharma
CBIO
CBIO
84 hedge funds and large institutions have $730M invested in Crescent Biopharma in 2018 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 31 increasing their positions, 21 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding
Funds holding: 84 → 84 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 24
Holders
84
Holding in Top 10
1
Calls
$1.53M
Puts
$1.01M
Top Buyers
| 1 | +$26.1M | |
| 2 | +$9.3M | |
| 3 | +$8.14M | |
| 4 |
O
OppenheimerFunds
New York
|
+$7.36M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$5.35M |
Top Sellers
| 1 | -$9.11M | |
| 2 | -$4.39M | |
| 3 | -$4.08M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$4.06M |
| 5 |
Goldman Sachs
New York
|
-$3.33M |